Loading...
McKesson Corporation
MCK•NYSE
HealthcareMedical - Distribution
$712.89
$1.29(0.18%)
McKesson Corporation (MCK) Financial Performance & Statements
Review McKesson Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
11.65%
↑ 11.65%
Operating Income Growth
-10.77%
↓ 10.77%
Net Income Growth
-15.67%
↓ 15.67%
Operating Cash Flow Growth
-16.38%
↓ 16.38%
Operating Margin
1.24%
↑ 1.24%
Gross Margin
3.66%
↑ 3.66%
Net Profit Margin
0.92%
↑ 0.92%
ROE
-132.73%
↓ 132.73%
ROIC
32.90%
↑ 32.90%
McKesson Corporation (MCK) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for McKesson Corporation stock.
| Metric | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| Revenue | $95.29B | $93.65B | $79.28B | $76.36B |
| Cost of Revenue | $92.01B | $90.40B | $76.33B | $72.89B |
| Gross Profit | $3.28B | $3.25B | $2.96B | $3.46B |
| Gross Profit Ratio | $0.03 | $0.03 | $0.04 | $0.05 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $77.00M |
| SG&A Expenses | $2.03B | $2.50B | $1.90B | $2.09B |
| Operating Expenses | $1.93B | $2.67B | $1.90B | $2.09B |
| Total Costs & Expenses | $89.98B | $93.07B | $78.22B | $74.98B |
| Interest Income | $0.00 | $0.00 | $0.00 | $118.00M |
| Interest Expense | $67.00M | $78.00M | $75.00M | $80.00M |
| Depreciation & Amortization | $153.00M | $163.00M | $169.00M | $160.00M |
| EBITDA | $1.45B | $775.00M | $1.32B | $1.41B |
| EBITDA Ratio | $0.02 | $0.008 | $0.02 | $0.02 |
| Operating Income | $1.22B | $578.00M | $1.06B | $1.37B |
| Operating Income Ratio | $0.01 | $0.006 | $0.01 | $0.02 |
| Other Income/Expenses (Net) | $2.00M | -$44.00M | $55.00M | -$46.00M |
| Income Before Tax | $1.23B | $534.00M | $1.08B | $1.17B |
| Income Before Tax Ratio | $0.01 | $0.006 | $0.01 | $0.02 |
| Income Tax Expense | $298.00M | $247.00M | $124.00M | $340.00M |
| Net Income | $879.00M | $241.00M | $915.00M | $791.00M |
| Net Income Ratio | $0.009 | $0.003 | $0.01 | $0.01 |
| EPS | $6.98 | $1.87 | $7.05 | $6.05 |
| Diluted EPS | $6.94 | $1.86 | $7.00 | $6.01 |
| Weighted Avg Shares Outstanding | $126.00M | $128.70M | $129.80M | $130.70M |
| Weighted Avg Shares Outstanding (Diluted) | $126.60M | $129.30M | $130.70M | $131.60M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan